Close Menu

MIT, Harvard, and Massachusetts General Hospital have teamed up to commercialize a new diagnostic that uses magnetic nanoparticles to detect viruses and bacteria, reports MIT’s Technology Review. The company, T2 Biosystems, has developed particles that are coated with molecules like antibodies or DNA; when exposed to a magnetic field, the particles bind to their target and form clumps that can be easily visualized.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A study of families explores how children transmit SARS-CoV-2, according to the Associated Press.

US Agricultural Research Service scientists have sequenced the genome of the Asian giant hornet.

According to the Economist, pooled testing for COVID-19 could help alleviate strains on testing labs.

In Science this week: MIT researchers outline approach dubbed translatable components regression to predict treatment response among IBD patients.